Zinopin® - The rationale for its use as a food supplement in traveller's thrombosis and motion sickness

Phytotherapy Research

Volumn 18, Issue 9, 2004, Pages 687-695

  Scurr, J H ^a   Gulati, O P ^b  

^a LISTER HOSPITAL   (United Kingdom)

^b Horphag Research   (Switzerland)

Author keywords

Clinical trial; Efficacy; Herbal food supplement; Motion sickness; Pycnogenol ; Review; Traveller's thrombosis; Zinopin

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; GINGER EXTRACT; GLUTATHIONE; HERBACEOUS AGENT; INTERCELLULAR ADHESION MOLECULE 1; LOW MOLECULAR WEIGHT HEPARIN; PYCNOGENOL; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA; WARFARIN; ZINOPIN; FLAVONOID; PLANT EXTRACT; PYCNOGENOLS;

ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG MIXTURE; HUMAN; LEG COMPRESSION; MOTION SICKNESS; PATHOPHYSIOLOGY; REVIEW; SYSTEMATIC REVIEW; THROMBOCYTE ACTIVATION; TRAVEL; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM; DIET SUPPLEMENTATION; GINGER; PHYTOTHERAPY; PLANT ROOT; THROMBOEMBOLISM;

ZINGIBER OFFICINALE;

DIETARY SUPPLEMENTS; FLAVONOIDS; GINGER; HUMANS; MOTION SICKNESS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; THROMBOEMBOLISM; TRAVEL;

EID: 8344277516     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1575     Document Type: Review

References (104)

1. Ahmed RS, Seth V, Pasha ST, Banerjee BD. 1998. Influence of dietary ginger (Zingiber officinale Rosc) on oxidative stress induced by malathione in rats. Food Chem Toxicol 38(5): 443-450.
2. Aikins-Murphy P. 1998. Alternative therapies for nausea and vomiting of pregnancy. Obstet Gynecol 91: 149-155.
3. Anonymous. 2000. Prevention of pulmonary embolism nd deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355: 1295-1302.
4. Araghi-Nicknam M, Hosseini S, Larson D, et al. 1999. Pine bark extract reduces platelet aggregation. Integrative Med 2(2/3): 73-77.
5. Arcangeli P. 2000. Pycnogenol® in chronic venous insufficiency. Fitoterapia 71: 236-244.
6. Arfeen Z, Owen H, Plummer JL, et al. 1995. A double blind randomised controlled trial of ginger for the prevention of post-operative nausea and vomiting. Anaest Intensive Care 23: 449-452.
7. Backon J. 1986. Ginger: inhibition of thrombaxane synthetase and stimulation of prostacyclin; relevance for medicine and psychiatry. Medical Hypothesis 20: 271-278.
8. Bayeta E, Benjamin MS, Lau HS. 2000. Pycnogenol inhibits generation of inflammatory mediators in macrophages. Nutrition Res 20(2): 249-259.
9. Belcaro G, Geroulakos G, Nicolaides AN, et al. 2001. Venous thromboembolism from air travel: the LONFLIT study. Angiology 52: 369-374.
10. Belcaro G, Geroulakos G, Nicolaides AN, et al. 2002. Prevention of deep vein thrombosis on long-haul flights. J Am Coll Cardiol 39(suppl 5): 212 A.
11. Bendz B, Rostrup M, Sevre K, et al. 2000. Association between acute hypobaric hypoxia and activation of coagulation in human beings. Lance 356: 1657-1658.
12. Bito T, Roy S, Sen CK, Packer L. 2000. Pine bark extract Pycnogenol down regulates IFN-γ-induced adhesion of T cells to human keratinocytes by inhibiting inducible ICAM-1 expression. Free Radical Biol Med 28(2): 219-227.
13. Blazso G, Gabor M, Sibbel R, Rohdewald P. 1994. Anti-inflammatory and superoxide radical scavenging activities of procyanidins containing extract from the bark of Pinus pinaster sol. and its fractions. Pharm Parmacol Let 3: 217-220.
14. Blazso G, Rohdewald P, Sibbel R, Gabor M. 1995. Anti-inflammatory activities of procyanidin-containing extracts from Pinus pinaster sol. Proceedings of the International Bioflavonoid Symposium, Vienna, Austria, Antus S, Gabor M, Vetschera K (eds). July 16-19, 1995; 231-238.
15. Blazso G, Gabor M, Rohdewald, P. 1997. Antiinflammatory activities of procyanidin containing extracts from Pinus pinaste Ait. after oral and cutaneous application. Pharmazie 52(5): 380-382.
16. Bone ME, Wilkinson DJ, Young JR, et al. 1990. Ginger root - a new antiemetic. The effect of ginger root on post-operative nausea and vomiting after major gynaecological surgery. Anaesthesia 45: 669-671.
17. Bordia A, Verma SK, Srivastava, KC. 1997. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronasry artery disease. Prostglandins Luekot Essent Fatty Acids 56: 379-384.
18. Cao JF, Chen ZG, Guo P, et al. 1993. Scavenging effects of ginger on Superoxide anion and hydroxyl radical. Zhongguo Zhong Yao Za Zhi 18(12): 750-751.
19. Cesarone MR, Belcaro G, Nicolaides AN et al. 2002. Venous thromboembolism from air travel: the Lonflit 3 study. Prevention with aspirin vs low-molecular weight-heparin (LMWH) in high-risk subjects: A randomized trial. Angiology 53: 1-6.
20. Cheung BS, Kohl RL, Money KE, Kinter LB. 1994. Etiologic significance of arginine vasopressin in motion sickness. J Clin Pharmacol 34: 664-670.
21. Chida M, Suzuki K, Nakanishi-Ueda T, et al. 1999. In vitro testing of antioxidants and biochemical end-points in bovine retinal tissue. Ophthalmic Res 31: 407-415.
22. Cho K-J Yun C-H, Yoon D-Y, et al. 2000. Effect of bioflavanoids extracted from the bark of Pinus maritime on proinflammatory cytokine interleukin.1 production in lipopolysaccharide-stimulated raw 264.7. Toxicol Applied pharmacol 1687: 64-71.
23. Clerel M, Caillard G. 1999. Thromboembolic syndrome from prolonged sitting and flights of long duration: experience of the Emergency Medical Service of the Paris Airports. Bull Acad Natl Med 183: 985-997.
24. Cruikshank JM, Gorlin J, Jennett B. 1988. Air travel and thrombotic episodes: the economy class syndrome. Lancet 2: 497-498.
25. Carruthers M, Arguelles AE, Mosovich A. 1976. Man in transit: biochemical and physiological changes during intercontinental flights. Lancet 1: 977-981.
26. Devraj S, Kaul N, Schönlau F, et al. 2002. Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters plasma lipoprotein profile. Lipids 37(10): 931-934.
27. Eklof B, Kistner RL, Masuda EM, et al. 1996. Venous thromboembolism in association with prolonged air travel. Dermatol Surg 22: 637-641.
28. Ernst E, Pittler MH. 2000. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesthesia 84(3): 367-371.
29. Ferrari E, Chevallier T, Chapelier A, Baudouy M. 1999. Travel as a risk factor for venous thromboembolic disease: a case-controlled study. Chest 115: 440-444.
30. Fischer-Rasmussen W, Kjaer SK, Dahl C, Asping, U. 1991. Ginger treatment of hyperemesis gravidarum. Eur J Obst Gynecol Reprod Biol 38: 19-24.
31. Fitzpatrick DF, Bing B, Rohdewald P. 1998. Endothelium-dependant vascular effects of Pycnogenol®. J Cardiovasc Pharmacol 32: 509-515.
32. Gertler JP, Perry L, L'Italian G, et al. 1993. Ambient oxygen tension modulates endothelial fibrinolysis. J Vasc Surg 18: 939-946.
33. Grimm T, Schäfer A, Höger P. 2004. Antioxidant activity and inhibition of matrixmetalloproteinases by metabolites of maritime pine bark extract (Pycnogenol). Free Radical Biol Med 36(6): 811-822.
34. Guh JH, Ko FN, Jong TT, Tenf CM. 1995. Antiplatelet effect of gingerol isolated from Zingiber officinale. J Pharm Pharmacol 47: 329-332.
35. Gulati OP, Sharma SC, Hammerson F. 1983b. Hemodynamic, biochemical and morphological changes in the Dextran and D-galactosamine-induced edema in rats. Arch Int Pharmacodynet de Therap 263(2): 272-286.
36. Gulati OP, Malmsten C, Ponard, G, Gulati, N. 1983a. The lcal edemogenic effects of leukotriene C4 and prostaglandin E2. Prostaglanis, Leukotrines Medicine 10: 11-17.
37. Gulati OP. 1999. Pycnogenol® in venous disorders: a review. Eur Bull Drug Res 7(2): 8-13.
38. Guochang Z. 1993. Ultraviolet radiation-induced oxidative stress in cultured human skin fibroblasts and antioxidant protection. Biol Rs Rep Univ Jyväskylä 33: 1-86.
39. Holtman S, Clarke AH, Scherer H, Hohn M. 1989. The anti-motion-sickness mechanism of ginger A comparative study with placebo and dimenhydrinate Acta Otolaryngol (Stockholm) 108(3-4): 168-174.
40. Homans J. 1954. Thrombosis of the deep leg veins due to prolonged sitting. N Engl J Med 250: 148-149.
41. Hosseini S, Lee J, Sepulveda RT, et al. 2001. A randomised, double-blind, placebo-controlled, prospective, 16 week crossover study to determine the role of Pycnogenol in modifying blood pressure in mildly hypertensive patients. Nutrition Res 21: 1251-1260.
42. International Consensus Statement. 1997. Prevention of venous thromboembolism (guidelines according to scientific evidence). Int Angiol 15: 1-36.
43. Jana U, Chattopathyay RN, Shaw BP. 1999 Preliminary studies on anti-inflammatory activity of Zingiber officinalis Rosc. Vitex negundo Linn and Tinospora cordifolia (Willid) Miers in albino rats. Ind J Pharmacol 31: 232-233.
44. Keating A, Chez RA. 2002. Ginger syrup as an antiemetic in early pregnancy. Altern Ther Health Med 8(5): 89-91.
45. Kim MS, Chey WD, Owyang C, Hasler WL. 1997. Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhrythmias in motion sickness. Am J Physiol 272(4 Pt 1): G853-G862.
46. Koch KL, Summy-Long J, Bingaman S, et al. 1990. Vasopressin and oxytocin responses illusory self-motion and nausea in man. J Clin Endocrinol Metab 71: 1269-1275.
47. Koch KL. 1999. Illusory self-motion and motion sickness: a model for brain-gut interactions and nausea Dig Dis Sci (8 Suppl): 53S-57S.
48. Koch R. 2002. Comparative study of Venostasin® and Pycnogenol® in chronic venous insufficiency. Phytotherapy Res 16: S1-S5.
49. Koo KL, Ammit AJ, Tran VH, et al. 2001. Gingerols and related alalogues inhibit arachidonic acid-induced human platelet serotonin release and ggregation. Thrombosis Res 103(5): 387-397.
50. Kraaijenhagen R, Haverkamp D, Koopman MMW, et al. 2000. Travel and risk of venous thrombosis. Lancet 356: 1492-1493.
51. Landgraf H, Vanselow B, Shulte-Huerman D, et al. 1994. Economy class syndrome: Rheology fluid balance nd lower leg oedema during simulated 12-hour long distance flight. Avat Space Envir Med 65: 930-935.
52. Lanner E, Greifenberg S, Gruenwald J. 1995. Ginger: History and Use. Advances Ther 15(1): 25-44.
53. Lien HC, Sun WM, Chen YH, et al. 1993. Effects of ginger on motion sickness and gastric slow-wave dysryhthemias induced by circular vecation. Am J Physiol Gastrointest Liver Physiol 284(3): 481-489.
54. Lloyd J, Bochner F. 1996. Aspirin: how low is low dose? Aust Presc 19: 79-81.
55. Lowe GDO, Greer JA, Cooke TG et al. 1992. Thromboembolic Risk Factors (THRIFT) Consensus Group-risk of prophylaxis for venous thromboembolism in hospital patients. Br Med J 305: 567-574.
56. Maritim A, Dene BA, Sanders RA, Watkins III JB. 2003. Effect of Pycnogenol treatment on the oxidative stress in Streptozotocin-Induced Diabetic rats. J Biochem Mol Toxicol 17(3): 193-199.
57. Mascolo N, Jain R, Jain SC, Capasso, F. 1989. Ethnopharmacological investigation of ginger (Zingiber officinale). J Ethanopharmacol 27: 129-140.
58. Mercer A, Brown JD. 1998. Venous thromboembolism associated with air travel. Aviat Space Environ Med 69: 154-157.
59. Minuz P, Lechi C, Gaino S, et al. 1995. Oxidized LDL and reduction of the antiaggregating activity of nitric oxide derived from endothelial cells. Throm Haemos 74: 1175-1179.
60. Mowrey DB, Clayson DE. 1982. Motion sickness, ginger and psychophysics. Lancet 53: 655-657.
61. Nelson A, Lau BHS, Ide, Rong, Y. 1998. Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation and hydroxyl radical-induced DNA damage. Drug Develop Industrial Pharmacy 24(2): 139-144.
62. Nordmann H, Gulati OP. 1980. Acute venous stasis and chronic venous insufficiency models in rats. Exp Meth Find Exptl Clin Pharmacol 5(6): 347-355.
63. Nordmann H, Auderset G, Broillet, A, Gulai, OP. 1982. Further investigations and pharmacologic results in the model of chronic venous insufficiency. In Experiment und Klinik, Voelter W, Jung G (eds). Springer Verlag; Berlin, Heidelberg New York, 93-107.
64. Nurtjahaja-Tjendraputra E, Amit AJ, Roufogalis BD, et al. 2003. Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Throbosis Res 111: 259-265.
65. Peng Q, Wei Z, Lau BHS. 2000. Pycnogenol® inhibits tumor necrosis factor-α(TNF-α)-induced nuclear factor kappa B activation, and adhesion molecule expression in human vascular endothelial cells. CMLS Cell Mol Life Sci 57: 834-841.
66. Packer L, Rimbach G, Virgili F. 1999. Antioxidant activity and biologic properties of a procyanidins-rich extract from the pine (Pinus maritima) bark, Pycnogenol. Free Rad Biol Med 27(5/6): 704-724.
67. Petrassi C, Mastromarino A, Spartera C. 2000. Pycnogenol® in chronic venous insufficiency. Phytomedicine 7(5): 383-388.
68. Phillips S, Ruggier R, Hutinson, SE. 1993. Zingiber officinale (ginger)- and antiemetic for day case surgery Anaesthesia 48: 715-717.
69. Pütter M, Grotemeyer KHM, Würthwein G, et al. 1999. Inhibition of smoking-induced platelet aggregation by aspirin and Pycnogenol. Thrombosis Res 95: 155-161.
70. Qian DS, Liu HS. 1992 Pharmacological studies of anti-motion sickness action of ginger. Chung Kuo Chung His Chieh Ho Tsa Chih 12(2): 95-98.
71. Rao GH. 1993. Physiology of blood platelet activation. Ind J Physiol Pharmacol. 37: 263-275.
72. Rao GH, Rao AT. 1994 Pharmacology of platelet activation-inhibitory drugs. Ind J Physiol Pharmacol 38: 69-84.
73. Rohdewald P. 1999. Pycnogenol®. In Flavonoids in Health and Disease, Rice-Evans CA, Packer L (eds). Marcel Dekker Inc.: New York; 405-419.
74. Rohdewald P. 2002. A review of the French maritime pine bark extract (Pycnogenol®), a herbal medication with a diverse clinical pharmacology. Int Jour Clin Pharmacol Therap 40(4): 158-168.
75. Rong Y, Li L, Shah V, Lau BHS. 1995. Pycnogenol protects vascular endothelial cells from t-butyl hydroperoxide induced oxidant injury. Biotechnol Therapeut 5(3&4): 117-126.
76. Saliou C, Rimback G, Moini H, et al. 2001. Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modified by French maritime pine bark extract. Free Rad Biol Med 30(2): 154-160.
77. Sarvesvaran R. 1986. Sudden and natural deaths associated with commercial air travel. Med Sci Law 26: 35-38.
78. Scurr JH, Machin SJ, Bailey-King S, et al. 2001. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet 357: 1485-1489.
79. Scurr JH, Baglin T, Burns CH et al. 1998. Second Thromboembolic Risk Factors (THRiFT II) Consensus Group-Risk of and Prophylaxis for Venous Thromboembolism in Hospital Patients. Phlebology 13: 87-97.
80. Scurr JH. 2002. Traveller's thrombosis. J R Soc Health 122(1): 11-13.
81. Sime S, Reeve V. 2004. Protection from inflammation, immunosuppression and carcinogenesis induced by UV radiation in mice by topical Pcnogenol®. Photochem Photobiol 79(2): 193-198.
82. Simons R, Krol R. 1996. Jet lag, pulmonary embolism, and hypoxia. Lancet 348: 416.
83. Srivastava KC. 1984. Effects of aqueous extracts of onion, garlic and ginger on platelet aggregation and metabolism of arachidonic acid in the blood vascular system: in vitro study. Prostglandins Luekot Med 13: 227-235.
84. Srivastava KC. 1986. Isolation and effect of some ginger components of platelet aggregation and eicosanoid biosynthesis. Prostaglandins Leukot Med 25: 187-198.
85. Srivastava KC. 1989. Effect of onion and ginger consumption on platelet thrombaxane production in humans. Prostaglandins, Lekot. Essential Fatty Acids 35: 183-185.
86. Stern RM, Koch KL, Stewart WR, Lindbla IM. 1987. Spectral analysis of tachygastria recorded during motion sickness. Gastroenterology 92: 92-97.
87. Stern RM, Hu SQ, Vasseey MW, Koch KL. 1989. Adaptation to vection induced symptoms of motion sickness. Aviat Space Environ Med 60: 556-572.
88. Stewart JJ, Wood MJ, Wood CD, Mims ME. 1991. Effects of ginger on motion sickness susceptibility and gastric function. Pharmacology 53: 111-120.
89. Suekawa M, Ishige A, Yuasa K, et al. 1984. Pharmacological studies on ginger. I Pharmacological actions of pungent constituents (6) - gingerol and (69) - shogol. J Pharmacobiodyn 7: 836-848.
90. Tardy B, Page Y, Zeni F, et al. 1993. Phlébite du transport-16 observations. Presse Medicale 22: 811-814.
91. Thomson M, Qattan KKA, Sawan SMA, et al. 2002. The use of ginger (zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins, Leukotriens Essental Fatty Acids. 67(6): 475-478.
92. Venkateshwarlu V. 1997. Cyclogenase inhibitors from spices. Indian Drugs J 34: 427-432.
93. Verma SK, Singh J, Khamesra R, Bordia A. 1993. Effect of ginger on platelet aggregation in man. Ind J Med Res 98: 240-242.
94. Verma SK, Bordia A 2001. Ginger, Fat and Fibrinolysis. Ind J Med Sci 55(2): 83-86.
95. Virchow R. 1856. Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Von Meidinger Sohn: Frankfort-am-Main.
96. Virgili F, Kobuchi H, Packer L. 1998a. Procyanidins extracted from Pinus maritima (Pycnogenol®) scavengers of free radical species and modulators of nitrogen monoxide metabolism in activated murine raw 264.7 macrophages. Free Radic Biol Med 24: 1120-1129.
97. Virgili F, Kobuchi H, Packer L. 1998b. Nitrogen monoxide (NO) metabolism: antioxidant properties and modulation of inducible NO synthase activity in activated macrophages by Procyanidins extracted from Pinus maritima (Pycnogenol®). In Flavonoids in Health and Disease, Catherine A, Rice-Evans CA, Lester Packer L (eds). Marcel Dekker Inc.: New York; 421-436.
98. Wang S, Tan D, Zhao Y, et al. 1999. The effect of Pycnogenol® on the microcirculation, platelet function and ischaemic myocardium in patients with coronary artery diseases. Eur Bull Drug Res 7(2): 19-25.
99. Watson RR. 1999. Reduction of cardiovascular disease risk factors by French Maritime Pine Bark Extract. Cardiovascular Reviews and Reports XX(VI): 326-329.
100. Watson RR. 2003. Pycnogenol® and cardiovascular health. Evidence based Integrative Medicine 1(1): 27-32.
101. Wei ZH, Peng QL, Lau BHS. 1997. Pycnogenol enhances endothelial cell antioxidant defences. Redox Report 3(4): 219-224.
102. Wenner A, Leu HJ, Spycher M, Brunner U. 1980. Ultrastructural changes of capillarie in chronic venous insufficiency. Exp Cell Biol 48: 1-14.
103. Xu LH, Koc KL, Summy-Long J, et al. 1993. Hypothalamic and gastric myelectrical responses during circular vecation-induced nausea in healthy Chinese subjects. Am J Physiol Endocrino Met 265: E578-E583.
104. Yamahara J, Huang QR, Li YH et al. 1990. Gastrointestinal enhancing effects of ginger and its active constituents. Chem Pharm Bull (Tokyo) 38(2): 430-431.